{"result": {"id": "6278896e-0a39-46ae-92b4-1ecbb940abd8", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"China's Hypertension and Cardiovascular Health Research Community\",\n    \"summary\": \"This community is centered around research and public health initiatives in China, focusing on hypertension, cardiovascular health, and related chronic diseases. Key entities include researchers like CHEN X and PALATINI P, institutions such as the National Center for Cardiovascular Diseases, and public health programs like the SMASH project and DECIDE-Salt study. These entities are interconnected through collaborative research, publications in journals like J Hypertens and Am J Hypertens, and participation in global health initiatives supported by the World Health Organization.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant public health challenges posed by hypertension and cardiovascular diseases in China, and the community's role in addressing these issues through research and policy.\",\n    \"findings\": [\n        {\n            \"summary\": \"Central role of China in hypertension and cardiovascular research\",\n            \"explanation\": \"China serves as a pivotal location for extensive research and public health initiatives targeting hypertension and cardiovascular diseases. The country's large population and high prevalence of hypertension make it a critical area for study and intervention. Research conducted in China has contributed to global understanding of hypertension management and prevention strategies. [Data: Entities (29, 1036, 1963); Relationships (915, 2518, 3247)]\"\n        },\n        {\n            \"summary\": \"Significance of the SMASH project and DECIDE-Salt study\",\n            \"explanation\": \"The SMASH project and DECIDE-Salt study are landmark initiatives in Shandong Province, China, focusing on salt reduction and its effects on blood pressure and cardiovascular health. These studies have demonstrated the benefits of low-sodium, high-potassium salt, influencing public health policies and interventions both in China and globally. [Data: Entities (1036, 2516, 1034); Relationships (2682, 2683, 2684, 908)]\"\n        },\n        {\n            \"summary\": \"Contributions of key researchers to hypertension management\",\n            \"explanation\": \"Researchers such as CHEN X, PALATINI P, and Williams B have made significant contributions to the field of hypertension through their studies on blood pressure variability, treatment strategies, and the development of clinical guidelines. Their work has been published in prestigious journals and has influenced hypertension management practices worldwide. [Data: Entities (2271, 2310, 2445); Relationships (2558, 2997, 2999)]\"\n        },\n        {\n            \"summary\": \"Impact of public health policies and guidelines\",\n            \"explanation\": \"The Chinese government and the State Council General Office have implemented comprehensive policies and guidelines for chronic disease prevention and control, including hypertension. These initiatives, such as the China Medium and Long-term Plan for the Prevention and Treatment of Chronic Diseases (2017-2025), aim to improve public health outcomes through early screening, treatment, and long-term management strategies. [Data: Entities (1963, 1964, 1973); Relationships (2292, 2293)]\"\n        },\n        {\n            \"summary\": \"Role of international collaboration and WHO support\",\n            \"explanation\": \"The World Health Organization (WHO) plays a crucial role in supporting hypertension and cardiovascular health initiatives in China through technical packages like the HEARTS technical package. International collaborations, such as those involving the ICPE and WHO, have facilitated cross-national research and the adoption of standardized diagnostic tools and treatment guidelines. [Data: Entities (23, 862); Relationships (24, 26, 2509, 2510)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751560555, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 759, "prompt_tokens": 9726, "total_tokens": 10485, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1472}, "prompt_cache_hit_tokens": 1472, "prompt_cache_miss_tokens": 8254}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n3271,DONGY,\"DongY is one of the authors of a study on secular trends in blood pressure and obesity in Chinese children published in Hypertension in 2018\"\"\",2\n2271,CHEN X,\"**CHEN X** is a researcher actively involved in studies related to blood pressure measurement, control, and screening, primarily focusing on populations in China. Their work encompasses comparative analyses of blood pressure measurement methods, as evidenced by their co-authorship of a study published in the *Journal of Hypertension (J Hypertens)* in 2022. Additionally, CHEN X has contributed to research on urinary sodium and potassium excretion, particularly as part of the **SMASH project** in Shandong province, China, which investigates the relationship between these electrolytes and blood pressure in adults. Their research has been published in prominent journals such as *Clinical Hypertension* and the *European Heart Journal*, highlighting their expertise in hypertension and cardiovascular health. Overall, CHEN X's work bridges clinical and epidemiological approaches to understanding and managing blood pressure-related health outcomes.\",6\n29,CHINA,\"China is a country where extensive research and public health initiatives related to cardiovascular health, hypertension, and chronic diseases have been conducted and implemented. Numerous epidemiological studies and analyses have been carried out in China, focusing on hypertension, nutrition, air pollution, and cardiovascular health across diverse populations, including children, the elderly, and rural residents. The country has developed age and height-specific blood pressure reference standards for males and females aged 3–17 years and is referenced in the Asia-Pacific cohort study for the strong correlation between blood pressure levels and stroke or coronary heart disease events.  \n\nChina faces significant health challenges, including a high prevalence of hypertension, with over 20 million people suffering from Grade 3 hypertension, as well as metabolic syndrome, particularly among women, the elderly, and rural populations. It also has the largest and fastest-aging elderly population, contributing to rising health concerns such as obesity and hypertension. Several intervention trials, including the SSaSS and DECIDE-Salt studies, have been conducted in China to improve hypertension management. Additionally, depression prevalence studies indicate a lifetime prevalence of 3.3–3.4%.  \n\nLong-term chronic disease prevention and control policies are being implemented in China, with plans extending until 2025. Health initiatives and dietary guidelines are actively promoted to address these public health challenges. China remains a key location for hypertension screening, control studies, and the development of evidence-based guidelines.\",33\n1036,SHANDONG PROVINCE,\"**Shandong Province** is a region in China where the **SMASH (Salt Substitute and Stroke Study) project** was conducted to study factors related to blood pressure, including urinary sodium and potassium excretion. The province is also recognized for its successful implementation of a **salt reduction program**, which contributed to public health improvements. These initiatives highlight Shandong's role in addressing cardiovascular health risks through dietary and lifestyle interventions.\",3\n3084,高尿酸血症相关疾病诊疗多学科共识专家组,A multidisciplinary expert group for the diagnosis and treatment of hyperuricemia-related diseases in China>,3\n322,NATIONAL NUTRITION PLAN (2017—2030),A national plan focused on nutrition and health in China from 2017 to 2030,2\n25,PHILLIPS,Researcher who led 2001-2005 depression prevalence studies across four Chinese provinces>,1\n26,HUANG,Researcher who conducted 2013-2015 epidemiological studies on depression in China>,1\n33,META-ANALYSIS 2013,\"Research synthesis showing China's depression prevalence rates (1.6% current, 2.3% annual, 3.3% lifetime)>\",1\n858,CHINESE HEALTH AND NUTRITION SURVEY,\"The Chinese Health and Nutrition Survey provides data on the increasing rates of overweight and obesity among urban and rural residents in China\"\"\",1\n859,CHINA SMOKING HARM HEALTH REPORT 2020,\"The China Smoking Harm Health Report 2020 highlights the severe health impacts of smoking, including over 1 million annual deaths in China due to tobacco use\"\"\",1\n2979,NATIONAL CENTER FOR GERIATRICS,The National Center for Geriatrics published guidelines for the diagnosis and treatment of diabetes in elderly Chinese patients,1\n308,MEDICINE (BALTIMORE),\"**MEDICINE (BALTIMORE)** is a medical journal dedicated to publishing clinical and scientific research across a broad spectrum of medical topics. It features studies on various health-related subjects, including depression, as well as research on blood pressure and mortality in rural Chinese elders. The journal serves as a platform for disseminating peer-reviewed medical research, contributing to advancements in healthcare and scientific understanding. While the descriptions highlight different focal areas, they collectively emphasize the journal's role in sharing high-quality medical studies with the global research community.\",1\n3091,HUO Y,Lead researcher in the CSPPT clinical trial on folic acid therapy>,2\n2310,PALATINI P,\"**PALATINI P** is a researcher with expertise in cardiovascular health, particularly in the field of hypertension. They have been involved in studies focusing on **short-term blood pressure variability** and the **management of hypertensive patients with elevated heart rate**. Additionally, PALATINI P authored a study on **isolated systolic hypertension in young individuals**, which was published in the *Journal of Hypertension (J Hypertens)* in 2018. Their work contributes to a deeper understanding of hypertension dynamics and treatment strategies for different patient populations.\",5\n2319,J HYPERTENS,,16\n3349,ACTION TRIAL,\"The **ACTION TRIAL** is a clinical trial that investigated the effects of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension. The study aimed to assess the impact of this treatment on patient outcomes, focusing on both survival rates and cardiovascular health complications. Both descriptions confirm the trial's primary objective, emphasizing its role in evaluating the efficacy of long-acting nifedipine in this specific patient population.  \n\nThe summary consolidates the provided descriptions into a coherent overview, ensuring clarity and consistency while retaining all key details.\",4\n3853,OMBONI S,\"OMBONI S is a researcher specializing in the field of hypertension management, with a focus on e-health and telemonitoring technologies. They have contributed to meta-analyses investigating the effectiveness of home blood pressure telemonitoring. Notably, OMBONI S was involved in a study on e-health applications for hypertension management, which was published in *Current Hypertension Reports* in 2020. Their work highlights their expertise in leveraging digital health tools to improve blood pressure monitoring and patient outcomes.\",4\n2317,XU SK,\"A researcher involved in a study comparing blood pressure measurement methods\"\"\",3\n3254,DONG J,\"Dong J is a researcher involved in studies across multiple medical fields, including volume management in peritoneal dialysis and hypertension prevalence in Chinese urban children. Their work spans both adult and pediatric populations, addressing critical health issues such as dialysis management and cardiovascular risk factors in urban settings. This demonstrates a broad research focus on nephrology and public health, particularly within the Chinese context.\",2\n2344,SK,\"Author of a study comparing blood pressure readings published in J Hypertens, 2022\"\"\",1\n3798,LIUK,A researcher analyzing genes involved in Mendelian forms of low-renin hypertension in Chinese early-onset hypertensive patients,1\n3821,QIN F,A researcher analyzing genetic factors in hypertension,1\n3822,SUN X,A researcher investigating Mendelian hypertension,1\n1963,CHINESE GOVERNMENT,\"The Chinese government has issued several policies and plans for chronic disease prevention and control, including the 'China Medium and Long-term Plan for the Prevention and Treatment of Chronic Diseases (2017-2025)'\"\"\",6\n1964,STATE COUNCIL GENERAL OFFICE,\"The **State Council General Office** issued the *\"\"Opinions on Promoting the Development of Internet + Medical Health\"\"* in 2018, advocating for the advancement of internet-based medical health services. This policy document supports the growth and integration of digital technologies in the healthcare sector, emphasizing the importance of \"\"Internet + medical health\"\" as a means to improve service accessibility and efficiency. Both descriptions confirm the office's role in releasing this directive, reinforcing its commitment to fostering innovation in medical health through digital solutions.\",3\n3078,AM J HYPERTENS,\"The *American Journal of Hypertension (AM J HYPERTENS)* is a medical journal dedicated to publishing research articles on hypertension. Its scope includes studies on medication adherence, blood pressure control, and related clinical topics. The journal has also featured meta-analyses on specific aspects of hypertension, such as bevacizumab-induced hypertension. Overall, it serves as a key resource for disseminating scientific and clinical advancements in the field of hypertension research.\",4\n1973,CHINA MEDIUM AND LONG-TERM PLAN FOR THE PREVENTION AND TREATMENT OF CHRONIC DISEASES (2017-2025),,2\n22,INTERNATIONAL CONSORTIUM OF PSYCHIATRIC EPIDEMIOLOGY (ICPE),An international research consortium that conducted a study on depression prevalence across 10 countries using WHO's CIDI tool>,2\n23,WORLD HEALTH ORGANIZATION (WHO),\"The **World Health Organization (WHO)** is an international organization headquartered in Geneva, Switzerland, serving as a global health authority. Among its key responsibilities, the WHO provides evidence-based guidelines for the pharmacological treatment of hypertension in adults, ensuring standardized and effective care worldwide. Additionally, the organization has developed critical research tools such as the **Composite International Diagnostic Interview (CIDI)**, which is widely used in depression research to assess mental health conditions. Through its guidelines and research initiatives, the WHO plays a pivotal role in advancing global public health policies and practices.\",5\n30,GLOBAL BURDEN OF DISEASE STUDY 2013,Landmark research event that identified depression as a leading cause of disability worldwide>,2\n275,PEOPLE'S MEDICAL PUBLISHING HOUSE,\"The **People's Medical Publishing House** is a prominent publisher based in Beijing, China, specializing in medical and healthcare-related literature. It is known for publishing authoritative works such as **Lu L's textbook on psychiatry**, the **Chinese Dietary Guidelines**, and the **translated edition of the Maudsley Prescribing Guidelines in Psychiatry**. These publications highlight the organization's role in disseminating critical medical knowledge, spanning both domestic and internationally recognized guidelines and textbooks. The People's Medical Publishing House serves as a key resource for healthcare professionals and students in China and beyond.\",4\n10,BEIJING,\"Beijing is the capital of China and serves as a major hub for healthcare, education, and publishing. The city is home to prominent medical institutions such as Peking Union Medical College Hospital, Peking University Sixth Hospital, and the National Center for Cardiovascular Diseases. Additionally, Beijing hosts key publishing entities like the People's Medical Publishing House, which operates in the city. It is also where the Chinese residents' dietary guidelines were published, reflecting its role in public health and policy dissemination. As the political and cultural center of China, Beijing plays a vital role in the nation's healthcare, academic, and publishing sectors.\",3\n1034,DECIDE-SALT,\"The Diet, Exercise and Cardiovascular Health-Salt (DECIDE-Salt) study is a cluster randomized controlled trial in elderly populations, demonstrating the benefits of low-sodium, high-potassium salt on blood pressure and cardiovascular health\",3\n1035,SHANDONG HEALTH DEPARTMENT SALT AND HYPERTENSION ACTION,\"The Shandong Health Department Salt and Hypertension Action is a population-based salt reduction program in China, recognized by the WHO Global Hypertension Report for its success in reducing sodium intake and improving blood pressure levels\",4\n1967,GUIDELINES ON PROMOTING THE CONSTRUCTION OF A TIERED MEDICAL TREATMENT SYSTEM,\"Policy establishing a tiered healthcare model with grassroots first diagnosis, two-way referrals, and coordinated care\"\"\",1\n862,WORLD HEALTH ORGANIZATION,\"The **World Health Organization (WHO)** is a specialized agency of the United Nations responsible for international public health. As a global health authority, WHO identifies air pollution as the largest environmental health threat worldwide and has conducted studies linking it to increased hypertension risk. Additionally, the organization plays a key role in addressing cardiovascular diseases, having published the **HEARTS technical package** in 2016 in Geneva to guide cardiovascular disease management in primary health care. WHO continues to provide technical resources and frameworks to improve global health outcomes, emphasizing both environmental risks and non-communicable disease prevention and management.\",5\n2291,GENEVA,,2\n2289,MAY MEASUREMENT MONTH 2018,\"May Measurement Month 2018 was a global blood pressure screening initiative that included results from China.\"\"\",1\n2512,GUO X,\"**GUO X** is a researcher primarily focused on public health and nutritional studies, particularly in Shandong province, China. Their work includes investigating the association of province-wide interventions with salt intake and hypertension, as well as examining urinary sodium and potassium excretion among adults. GUO X has been involved in the **SMASH project** (Shandong-Ministry of Health Action on Salt Reduction and Hypertension), which studies the relationship between sodium and potassium excretion and blood pressure. Their research contributes to understanding dietary influences on hypertension and supports broader public health initiatives aimed at reducing salt consumption and improving cardiovascular health.\",3\n2516,SMASH PROJECT,A project studying urinary sodium/potassium excretion and blood pressure in adults,4\n2513,MA J,\"**MA J** is a researcher primarily focused on public health and epidemiological studies in China, with a particular emphasis on blood pressure trends, salt intake, and hypertension. Their work includes contributions to studies on blood pressure trends in Chinese youth, as well as involvement in the **SMASH project**, which investigates urinary sodium and potassium excretion in **Shandong province, China**. Additionally, MA J has researched the association between a province-wide intervention and its effects on salt intake and hypertension in the same region. Their broader research interests also encompass studies on urinary sodium and potassium excretion and their relationship to blood pressure in adults. Overall, MA J's work highlights a strong focus on dietary factors, hypertension, and cardiovascular health in both youth and adult populations in China.\",3\n2445,WILLIAMS B,\"**Williams B** is a prominent researcher and author in the field of hypertension, with significant contributions to clinical guidelines and studies on treatment strategies. He is recognized as a contributor to the **ESC/ESH hypertension guidelines**, which are influential in shaping clinical practice. His research focuses on various aspects of hypertension management, including **combination therapy**, **diuretics**, and **drug-resistant hypertension**.  \n\nOne of his key contributions includes co-authoring the **PATHWAY-2 study**, which investigated the efficacy of **spironolactone** compared to placebo, bisoprolol, and doxazosin in treating drug-resistant hypertension. This study played a crucial role in determining optimal treatment approaches for resistant cases.  \n\nOverall, Williams B's work spans guideline development, comparative effectiveness research, and therapeutic innovations, establishing him as a leading figure in hypertension research.\",4\n2854,MACDONALD TM,\"**MACDONALD TM** is a researcher and author associated with studies on combination therapy for hypertension, particularly focusing on drug-resistant hypertension. Notably, MacDonald TM contributed to the **PATHWAY-2 study**, which investigated the efficacy of **spironolactone** compared to placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension. This work underscores MacDonald TM's involvement in advancing therapeutic strategies for managing complex hypertension cases.\",3\n2903,PATHWAY-2,,3\n3864,CURR HYPERTENS REP,\"Journal that published a study on e-health in hypertension management in 2020\"\"\",3\n274,LU L,\"Lu L is the author of Shen Yucun's Psychiatry, a textbook published by People's Medical Publishing House in 2018\"\"\",2\n863,CHINA HEALTH AND RETIREMENT LONGITUDINAL STUDY,\"A study in China that found air pollution contributes to increased hypertension risk\"\"\",1\n1033,SSASS,\"The Salt Substitute and Stroke Study (SSaSS) is a research study conducted among stroke patients and high-risk stroke patients in China, showing that low-sodium, high-potassium salt significantly reduces blood pressure, stroke, and cardiovascular events\",3\n1965,14TH FIVE-YEAR PLAN,\"The latest '14th Five-Year Plan' includes detailed regulations for the chronic disease management industry, emphasizing the construction of a public health system and early screening for chronic diseases\"\"\",3\n1966,BASIC PUBLIC HEALTH SERVICE SPECIFICATIONS,\"This specification outlines the hypertension prevention and treatment service system, including screening, diagnosis, treatment, and long-term follow-up services\"\"\",3\n2254,TECHNICAL PACKAGE,,1\n2269,HEARTS TECHNICAL PACKAGE,,1\n2325,SALADINI F,\"A researcher involved in a study on short-term blood pressure variability\"\"\",1\n2326,MOS L,\"A researcher involved in a study on short-term blood pressure variability\"\"\",1\n2674,ADVANCE COLLABORATIVE GROUP,A group conducting trials on the effects of perindopril and indapamide in diabetic patients,1\n2859,MORANT S,\"Morant S is one of the authors of the PATHWAY-2 study on spironolactone for drug-resistant hypertension\"\"\",3\n3083,中国医疗保健国际交流促进会高血压分会共识专家组,A Chinese expert group focused on hypertension management and consensus development>,3\n3860,PANZERI E,\"Panzeri E is a researcher who contributed to a study on e-health in hypertension management published in Curr Hypertens Rep in 2020\"\"\",3\n3861,CAMPOLO L,\"Campolo L is a researcher who contributed to a study on e-health in hypertension management published in Curr Hypertens Rep in 2020\"\"\",3\n300,SI TM,\"Translator of the Maudsley Prescribing Guidelines in Psychiatry\"\"\",1\n1037,WHO GLOBAL HYPERTENSION REPORT,,1\n1970,COMMUNITY PRIMARY HEALTHCARE SYSTEM,\"Grassroots medical institutions forming the first tier of China's three-layer health service system\"\"\",2\n2300,\"NATIONAL CENTER FOR CARDIOVASCULAR DISEASES, CHINA\",\"A research center that published the 2022 report on cardiovascular health and diseases in China\"\"\",2\n2535,XU A,\"Xu A is a researcher who studied the association of a province-wide intervention with salt intake and hypertension in Shandong province, China>\",2\n2527,MA Y,\"MA Y is a researcher whose work focuses on cardiovascular and neurological health. They have studied the relationship between 24-hour urinary sodium and potassium excretion and cardiovascular risk, as well as reviewed the connection between blood pressure variability and dementia. Their research spans both metabolic and neurological aspects of health, contributing to a broader understanding of risk factors in these areas.\",3\n2528,HE FJ,He FJ is a researcher who studied 24-hour urinary sodium and potassium excretion and cardiovascular risk>,2\n2529,SUN Q,Sun Q is a researcher who studied 24-hour urinary sodium and potassium excretion and cardiovascular risk>,2\n2189,CHEN Y,\"**CHEN Y** is a researcher primarily focused on hypertension-related studies, with a particular emphasis on pediatric hypertension, type 2 diabetes, and predictive modeling in Chinese populations. Their work includes investigating intensive blood pressure lowering strategies in patients with type 2 diabetes, as well as developing and validating prediction models for incident hypertension in Chinese cohorts. CHEN Y's research spans clinical and epidemiological aspects of hypertension, contributing to advancements in understanding and managing the condition across different patient groups, including children and adults with diabetes. Their studies highlight a consistent focus on hypertension within the context of China's healthcare landscape.\",3\n3267,MULTICENTER PEDIATRIC HYPERTENSION STUDY IN CHINA,\"A nationwide study of clinical characteristics of pediatric hypertension in China\"\"\",2\n3384,LUBSEN J,\"LUBSEN J is a researcher who was involved in the ACTION trial, a study focused on investigating the effects of nifedipine. The descriptions highlight their participation in this clinical trial, though no additional details about their specific role or contributions are provided. Both descriptions consistently identify LUBSEN J's association with the ACTION trial, reinforcing their involvement in this research.\",1\n3385,WAGENER G,\"WAGENER G is a researcher who was involved in the ACTION trial, a study focused on investigating the effects of nifedipine. The descriptions consistently highlight their participation in this clinical trial, emphasizing their role in researching the impact of the medication. No contradictory information was provided.\",1\n3386,KIRWAN BA,\"KIRWAN BA is a researcher who was involved in the ACTION trial, a study focused on investigating the effects of nifedipine. The trial examined the impact and potential benefits of this medication, with KIRWAN BA contributing to its research efforts. Both descriptions confirm their participation in this clinical study, reinforcing their role in the project.\",1\n3847,FRIEDMAN RH,A researcher involved in telecommunications systems for hypertension monitoring and counseling,1\n4613,CHINESE RESIDENTS' DIETARY GUIDELINES (2022),\"Publication of dietary guidelines for cardiovascular disease prevention in China\"\"\",2\n32,COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW (CIDI),WHO's standardized diagnostic tool used in depression epidemiology studies>,2\n34,MAJOR DEPRESSIVE DISORDER (MDD),,2\n321,HEALTH CHINA ACTION (2019—2030),A national health initiative aimed at improving public health in China from 2019 to 2030,2\n1968,NOTICE ON IMPROVING LONG-TERM PRESCRIPTION MANAGEMENT FOR CHRONIC DISEASES,\"Regulation allowing 12-week prescriptions for stable chronic disease patients with remote follow-up requirements\"\"\",1\n1969,INTERNET+ MEDICAL HEALTH DEVELOPMENT OPINIONS,\"State Council policy promoting digital healthcare innovation while setting regulatory boundaries\"\"\",1\n1972,URBAN GENERAL HOSPITALS,\"Third-tier tertiary medical institutions in China's healthcare system\"\"\",2\n2339,SHENG CS,\"A researcher involved in a study comparing blood pressure measurement methods\"\"\",1\n2750,REBOLDIG,\"ReboldiG is a researcher who contributed to meta-analyses comparing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.\"\"\",3\n2751,ANGELIF,\"AngeliF is a researcher involved in studies on cardiovascular treatments and meta-analyses.\"\"\",1\n2752,CAVALLINIC,\"CavalliniC is a researcher who co-authored meta-analyses on cardiovascular treatments.\"\"\",1\n2757,BURNIERM,\"BurnierM is a researcher who studied the redefinition of diuretics use in hypertension.\"\"\",3\n2758,BAKRIS G,\"Bakris G is a researcher involved in studies on diuretics and hypertension treatments.\"\"\",1\n2764,CHALMERSJ,\"ChalmersJ is a researcher who analyzed the benefits of treatment based on indapamide combined with perindopril on mortality and cardiovascular outcomes.\"\"\",3\n2765,MOURADJJ,\"MouradJJ is a researcher involved in pooled analyses of trials on indapamide and perindopril.\"\"\",1\n2766,BRZOZOWSKA-VILLATTER,\"Brzozowska-VillatteR is a researcher who co-authored analyses of trials on cardiovascular treatments.\"\"\",1\n3086,CSPPT,A randomized clinical trial group studying folic acid therapy for stroke prevention in hypertensive patients>,2\n3265,CHINESE URBAN CHILDREN HYPERTENSION STUDY,\"A study examining hypertension prevalence in Chinese urban children\"\"\",2\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n3395,DONGY,HYPERTENSION,DongY published their study in this journal,185\n2518,CHEN X,CHINA,Chen X conducted research on blood pressure control in China.,39\n915,SHANDONG PROVINCE,CHINA,Shandong Province is part of China where the successful salt reduction program was implemented,36\n3247,高尿酸血症相关疾病诊疗多学科共识专家组,CHINA,The expert group operates in China,36\n328,NATIONAL NUTRITION PLAN (2017—2030),CHINA,The nutrition plan is implemented nationwide in China,35\n29,PHILLIPS,CHINA,Phillips conducted depression prevalence research across four Chinese provinces,34\n30,HUANG,CHINA,Huang led 2013-2015 depression epidemiology studies in China,34\n32,CHINA,META-ANALYSIS 2013,The meta-analysis compiled depression prevalence data specific to China,34\n680,CHINA,CHINESE HEALTH AND NUTRITION SURVEY,\"The Chinese Health and Nutrition Survey collects data on health trends in China, including rising obesity rates\",34\n681,CHINA,CHINA SMOKING HARM HEALTH REPORT 2020,The China Smoking Harm Health Report 2020 documents the impact of smoking on public health in China,34\n3108,NATIONAL CENTER FOR GERIATRICS,CHINA,The National Center for Geriatrics is based in China,34\n3365,CHINA,MEDICINE (BALTIMORE),Medicine published research conducted in China on elderly hypertension,34\n3260,HUO Y,STROKE,Researcher studied stroke prevention,29\n2558,PALATINI P,J HYPERTENS,\"**PALATINI P** and **J HYPERTENS**: Palatini P co-authored and published a study in the journal *J Hypertens*. The research, authored by Palatini P, was featured in *J Hypertens*, highlighting their contribution to the field of hypertension through this publication. The descriptions collectively confirm Palatini P's involvement in a study published in *J Hypertens* without any contradictions.\",21\n3473,ACTION TRIAL,J HYPERTENS,The trial's findings were published in the Journal of Hypertension,20\n3827,OMBONI S,J HYPERTENS,Omboni S published meta-analyses in J Hypertens on telemonitoring,20\n2573,XU SK,J HYPERTENS,Xu SK co-authored a study published in J Hypertens,19\n3383,J HYPERTENS,DONG J,Dong J published research in the Journal of Hypertension on hypertension prevalence in Chinese urban children.,18\n2579,SK,J HYPERTENS,SK authored a study published in J Hypertens,17\n3790,J HYPERTENS,LIUK,LiuK published a study in J Hypertens,17\n3791,J HYPERTENS,QIN F,Qin F co-authored research published in J Hypertens,17\n3792,J HYPERTENS,SUN X,Sun X collaborated on hypertension research published in J Hypertens,17\n2289,CHINESE GOVERNMENT,STATE COUNCIL GENERAL OFFICE,The State Council General Office is part of the Chinese government and issues health policies,9\n3235,PALATINI P,AM J HYPERTENS,Palatini P published research in Am J Hypertens,9\n2292,CHINESE GOVERNMENT,CHINA MEDIUM AND LONG-TERM PLAN FOR THE PREVENTION AND TREATMENT OF CHRONIC DISEASES (2017-2025),The plan was formulated and implemented by the Chinese government,8\n24,INTERNATIONAL CONSORTIUM OF PSYCHIATRIC EPIDEMIOLOGY (ICPE),WORLD HEALTH ORGANIZATION (WHO),ICPE used WHO's CIDI methodology for cross-national depression research,7\n26,WORLD HEALTH ORGANIZATION (WHO),GLOBAL BURDEN OF DISEASE STUDY 2013,The study contributed to WHO's understanding of depression's global impact,7\n307,PEOPLE'S MEDICAL PUBLISHING HOUSE,BEIJING,The publisher is located in Beijing,7\n911,DECIDE-SALT,SHANDONG HEALTH DEPARTMENT SALT AND HYPERTENSION ACTION,The Shandong Health Department's program aligns with the findings of the DECIDE-Salt study on the benefits of salt reduction,7\n2293,CHINESE GOVERNMENT,GUIDELINES ON PROMOTING THE CONSTRUCTION OF A TIERED MEDICAL TREATMENT SYSTEM,Issued by the Chinese government to reform healthcare delivery,7\n2517,WORLD HEALTH ORGANIZATION,GENEVA,The World Health Organization published its HEARTS technical package in Geneva.,7\n2519,CHEN X,MAY MEASUREMENT MONTH 2018,Chen X analyzed blood pressure screening results from China during May Measurement Month 2018.,7\n2682,GUO X,SMASH PROJECT,Guo X is a researcher involved in the SMASH project,7\n2683,MA J,SMASH PROJECT,Ma J is a researcher involved in the SMASH project,7\n2684,SMASH PROJECT,SHANDONG PROVINCE,The SMASH project was conducted in Shandong Province,7\n2997,WILLIAMS B,MACDONALD TM,Williams B and MacDonald TM are co-authors of the PATHWAY-2 study,7\n2999,WILLIAMS B,PATHWAY-2,Williams B is an author of the PATHWAY-2 study,7\n3838,OMBONI S,CURR HYPERTENS REP,Omboni S published research in Curr Hypertens Rep,7\n287,LU L,PEOPLE'S MEDICAL PUBLISHING HOUSE,Lu L's textbook was published by People's Medical Publishing House,6\n684,WORLD HEALTH ORGANIZATION,CHINA HEALTH AND RETIREMENT LONGITUDINAL STUDY,Both entities have conducted research linking air pollution to hypertension,6\n908,SSASS,DECIDE-SALT,\"Both SSaSS and DECIDE-Salt are studies investigating the effects of low-sodium, high-potassium salt on health outcomes\",6\n2296,14TH FIVE-YEAR PLAN,BASIC PUBLIC HEALTH SERVICE SPECIFICATIONS,Both are part of China's health policy framework for chronic disease management,6\n2509,WORLD HEALTH ORGANIZATION,TECHNICAL PACKAGE,The World Health Organization provides a technical package for cardiovascular disease management,6\n2510,WORLD HEALTH ORGANIZATION,HEARTS TECHNICAL PACKAGE,WHO developed this package for cardiovascular disease management,6\n2559,PALATINI P,SALADINI F,Palatini P and Saladini F co-authored a study on blood pressure variability,6\n2560,PALATINI P,MOS L,Palatini P and Mos L co-authored a study on blood pressure variability,6\n2816,ADVANCE COLLABORATIVE GROUP,WORLD HEALTH ORGANIZATION (WHO),Both are involved in hypertension treatment research,6\n3000,MACDONALD TM,MORANT S,MacDonald TM and Morant S are co-authors of the PATHWAY-2 study,6\n3002,MORANT S,PATHWAY-2,Morant S is an author of the PATHWAY-2 study,6\n3244,中国医疗保健国际交流促进会高血压分会共识专家组,高尿酸血症相关疾病诊疗多学科共识专家组,Both are Chinese expert groups focused on hypertension and hyperuricemia management,6\n3839,PANZERI E,CAMPOLO L,Panzeri E and Campolo L are co-authors of a study on e-health in hypertension management,6\n3841,CAMPOLO L,CURR HYPERTENS REP,Campolo L published research in Curr Hypertens Rep,6\n306,SI TM,PEOPLE'S MEDICAL PUBLISHING HOUSE,SI TM translated the Maudsley Prescribing Guidelines published by People's Medical Publishing House,5\n913,SHANDONG HEALTH DEPARTMENT SALT AND HYPERTENSION ACTION,WHO GLOBAL HYPERTENSION REPORT,The WHO report recognized and recommended Shandong's salt reduction program as an effective hypertension intervention,5\n2298,BASIC PUBLIC HEALTH SERVICE SPECIFICATIONS,COMMUNITY PRIMARY HEALTHCARE SYSTEM,The specifications define service standards for grassroots institutions,5\n2546,\"NATIONAL CENTER FOR CARDIOVASCULAR DISEASES, CHINA\",BEIJING,The National Center for Cardiovascular Diseases is located in Beijing,5\n2685,GUO X,XU A,Xu A and Guo X collaborated on a study about salt intake and hypertension in Shandong province,5\n2699,MA Y,HE FJ,Ma Y and He FJ collaborated on a study about urinary sodium and potassium excretion and cardiovascular risk,5\n2700,MA Y,SUN Q,Ma Y and Sun Q collaborated on a study about urinary sodium and potassium excretion and cardiovascular risk,5\n3388,CHEN Y,MULTICENTER PEDIATRIC HYPERTENSION STUDY IN CHINA,Chen Y participated in the multicenter study of pediatric hypertension,5\n3474,ACTION TRIAL,LUBSEN J,\"The ACTION trial was a study investigating the effects of nifedipine, led by researcher Lubsen J. Lubsen J played a key role in the trial as one of the involved researchers. Together, these contributions highlight Lubsen J's leadership and participation in the ACTION trial, which focused on assessing the impact of nifedipine.\",5\n3479,ACTION TRIAL,WAGENER G,Wagener G was a researcher involved in the ACTION trial,5\n3480,ACTION TRIAL,KIRWAN BA,Kirwan BA was a researcher involved in the ACTION trial,5\n3822,FRIEDMAN RH,AM J HYPERTENS,Friedman RH published research in Am J Hypertens on hypertension monitoring,5\n4475,BEIJING,CHINESE RESIDENTS' DIETARY GUIDELINES (2022),The guidelines were published in Beijing,5\n25,INTERNATIONAL CONSORTIUM OF PSYCHIATRIC EPIDEMIOLOGY (ICPE),COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW (CIDI),ICPE utilized WHO's CIDI for multinational depression prevalence studies,4\n33,GLOBAL BURDEN OF DISEASE STUDY 2013,MAJOR DEPRESSIVE DISORDER (MDD),The study identified MDD as a leading global cause of disability,4\n326,HEALTH CHINA ACTION (2019—2030),NATIONAL NUTRITION PLAN (2017—2030),Both are national initiatives aimed at improving health and nutrition in China,4\n2294,STATE COUNCIL GENERAL OFFICE,NOTICE ON IMPROVING LONG-TERM PRESCRIPTION MANAGEMENT FOR CHRONIC DISEASES,Regulation published by the State Council office,4\n2295,STATE COUNCIL GENERAL OFFICE,INTERNET+ MEDICAL HEALTH DEVELOPMENT OPINIONS,Policy document released by the State Council office,4\n2299,COMMUNITY PRIMARY HEALTHCARE SYSTEM,URBAN GENERAL HOSPITALS,Part of the same three-tier healthcare system with referral relationships,4\n2575,XU SK,SHENG CS,Xu SK and Sheng CS co-authored a study on blood pressure measurement methods,4\n2701,HE FJ,SUN Q,He FJ and Sun Q collaborated on a study about urinary sodium and potassium excretion and cardiovascular risk,4\n2894,REBOLDIG,ANGELIF,ReboldiG and AngeliF co-authored meta-analyses comparing cardiovascular treatments.,4\n2895,REBOLDIG,CAVALLINIC,ReboldiG and CavalliniC collaborated on research related to hypertension treatments.,4\n2902,BURNIERM,BAKRIS G,BurnierM and Bakris G co-authored studies on diuretics and hypertension.,4\n2910,CHALMERSJ,MOURADJJ,ChalmersJ and MouradJJ co-authored pooled analyses of cardiovascular trials.,4\n2911,CHALMERSJ,BRZOZOWSKA-VILLATTER,ChalmersJ and Brzozowska-VillatteR collaborated on research related to indapamide and perindopril.,4\n3251,CSPPT,HUO Y,Huo Y led the CSPPT clinical trial on folic acid therapy,4\n3386,DONG J,CHINESE URBAN CHILDREN HYPERTENSION STUDY,Dong J conducted research on hypertension prevalence in Chinese urban children,4\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_cb7ac4694efa07194897cea6b192fe3eb932ca6e7d4014496f9933d9d7ce03b9_v2"}